氪红激光凝治疗增殖型糖尿病性视网膜病变  

Krypton Red Laser Photocoagulation for Proliferative Diabetic Retinopathy

作　　者：赵娟 庞利民[2] 拱中华[2] 张晓猛[2] 

机构地区：[1]长春铁路医院眼科,130051 [2]白求恩医科大学第二临床学院眼科

出　　处：《中国实用眼科杂志》2001年第3期190-191,共2页Chinese Journal of Practical Ophthalmology

摘　　要：观察氪红激光光凝治疗增殖型糖尿病性视网膜病变的疗效。方法 :对患有增殖型糖尿病性视网膜病变伴有屈光间质混浊或轻度玻璃体积血的 147例 2 0 9眼进行了氪红激光全视网膜光凝治疗。结果 :患者治疗前和治疗后视力无明显差异 ( P>0 .0 5 )。全视网膜光凝术后视盘和视网膜的新生血管部分消退。结论 :氪激光光凝对于那些氩激光无法治疗的伴有屈光间质混浊或轻度玻璃体积血的增殖型糖尿病性视网膜病变是有效的治疗方法 ,可使新生血管消退 。To assess the effectiveness of krypton red laser photocoagulation for proliferative diabetic retinopathy(PRD).Mehtods:147PDR patients(209 eyes)with media opacities or vitreous hemorrhage received krypton red laser panretinal photocoagulation(PRP).Results:The statistical results indicated that there was no significant difference of the visual acuity in all patients before and after treament(P>0.05).partial regression of disc neovascularization and retinal neovascularization was obtained after krypton red laser PRP.Conclusion:The results of this research demonstrated that krypton red laser PRP is effective in treament of PDR patients with media opacities of vitrous hemorrhage which cant be treated by argon laser and it can make neovascularization regression and avoid hemorrhage again.

关 键 词：增殖型糖尿病性视网膜病变 全视网膜光凝术 氪红激光 

分 类 号：R774.130.5[医药卫生—眼科] R779.63[医药卫生—临床医学]